ETERNITY HEALTH
LIVE

Serial Number

79280388

Owner

flyinghealth GmbH

Attorney

Timothy R. DeWitt

Filing Date

Dec 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ETERNITY HEALTH Trademark

Serial Number: 79280388 • Registration: 6263412

ETERNITY HEALTH is a trademark filed by flyinghealth GmbH on December 17, 2019. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

flyinghealth GmbH (5 trademarks)

Berlin 13465 , DE

Entity Type: 27

Eternity.Health GmbH (2 trademarks)

Askaloner Weg 4

Entity Type: 99

Trademark Details

Filing Date

December 17, 2019

Registration Date

February 9, 2021

Published for Opposition

November 24, 2020

Goods & Services

Business organization and operation consultancy; advisory services relating to business management and business operations; market advisory services namely, market research; organizational consultancy and business administration, with and without the aid of electronic databases; business planning services; business management consulting services in the field of information technology; computerized business management services for others; computerized mallet research services; Acquisition and merger consultation, namely, business merger services; business services, namely assisting others in the establishment of businesses; Marketing research services, namely, conducting market research surveys for qualitative market research; business strategy development services; development of hospital management systems; development of marketing strategies and concepts; business development services; business management; business management services relating to the acquisition of businesses; management of health care ethics for others; hospital management, business assistance relating to the formation of commercial undertakings; business project management; human resources management and recruitment services; business risk assessment services; business acquisitions consultation; business advice relating to marketing; business advisory services relating to company performance; business merger consultation; business consultancy services relating to insolvency, business advice relating to marketing management consultations; business advice relating to strategic marketing business advisory; services relating to business liquidations; business advice relating to the sale of businesses; business advice relating to growth financing business consultation and business management regarding launching of new products; business administration; business and market research; business management supervision

Facilitating and arranging for the financing of companies and projects in the pharmaceutical, medical device, digital health and healthcare industries; investment consultancy-, equity financing services; financial consultancy in relation to the buying and selling of businesses; financial advisory and financial management services; Facilitating and arranging for the financing of health care; financing in relation to the buying and selling of businesses; financing of business mergers; financing of business acquisitions; financial management of holding companies; fund management, namely, Management of private equity and venture capital funds; investment advisory services; real estate escrow services; arranging finance for businesses, namely, Business finance procurement services; financial management

Information technology [IT] consultancy services; computer technology and information technology consultancy services; Computer programing services, namely, information technology programing services; information technology consulting services for the pharmaceutical and healthcare industries; advisory services relating to science, namely, technological advisory services relating to machine engineering analysis; scientific research services and design relating thereto in the field of pharmaceutical, medical device, digital health and healthcare; scientific research services; scientific and technological services, namely, namely scientific research, analysis, and testing in the field of pharmaceutical, medical device, digital health and healthcare industries

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 9, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 12, 2021 FICS
FINAL DISPOSITION PROCESSED
May 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 9, 2021 FICR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 8, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 8, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2020 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2020 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 18, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 18, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2020 NONP
CHANGE OF OWNER RECEIVED FROM IB
Oct 31, 2020 CHLD
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 13, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 5, 2020 REPR